Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave

Acorda Parkinson’s Drug Launched, Exec Hindman Is Now Set to Leave

Source: 
Xconomy
snippet: 

Acorda Therapeutics (NASDAQ: ACOR), which has just launched a new Parkinson’s disease treatment, is saying farewell to chief business officer Andrew Hindman.